A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. - Puskarich MA; Cummins NW; Ingraham NE; Wacker DA; Reilkoff RA; Driver BE; Biros MH; Bellolio F; Chipman JG; Nelson AC; Beckman K; Langlois R; et al. (EClinicalMedicine, 2021)